What should work, may not.
Publication
, Other
Kirk, AD
Published in: Am J Transplant
March 2010
When new agents such as bortezomib appear, it is important to maintain scientific rigor regarding off-label use of medications.
Duke Scholars
Published In
Am J Transplant
DOI
EISSN
1600-6143
Publication Date
March 2010
Volume
10
Issue
3
Start / End Page
447 / 448
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Surgery
- Research Design
- Pyrazines
- Organ Transplantation
- Off-Label Use
- Immunosuppressive Agents
- Humans
- Drug Prescriptions
Citation
APA
Chicago
ICMJE
MLA
NLM
Kirk, A. D. (2010). What should work, may not. Am J Transplant. United States. https://doi.org/10.1111/j.1600-6143.2010.03025.x
Kirk, A. D. “What should work, may not.” Am J Transplant, March 2010. https://doi.org/10.1111/j.1600-6143.2010.03025.x.
Kirk AD. What should work, may not. Vol. 10, Am J Transplant. 2010. p. 447–8.
Kirk, A. D. “What should work, may not.” Am J Transplant, vol. 10, no. 3, Mar. 2010, pp. 447–48. Pubmed, doi:10.1111/j.1600-6143.2010.03025.x.
Kirk AD. What should work, may not. Am J Transplant. 2010. p. 447–448.
Published In
Am J Transplant
DOI
EISSN
1600-6143
Publication Date
March 2010
Volume
10
Issue
3
Start / End Page
447 / 448
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Surgery
- Research Design
- Pyrazines
- Organ Transplantation
- Off-Label Use
- Immunosuppressive Agents
- Humans
- Drug Prescriptions